Package 69238-1422-8

{"route": ["ORAL"], "spl_id": "b9db3e35-7654-4bf3-8536-38f56b8780c7", "openfda": {"upc": ["0369238142266"], "unii": ["TC2D6JAD40", "9TN87S3A3C"], "rxcui": ["1550957"], "spl_set_id": ["caca14cf-95f2-4c60-8bba-2154b8f353a3"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (69238-1422-2)  / 20 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "69238-1422-2", "marketing_start_date": "20181023"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (69238-1422-4)  / 40 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "69238-1422-4", "marketing_start_date": "20181023"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (69238-1422-6)  / 160 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "69238-1422-6", "marketing_start_date": "20181023"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (69238-1422-8)  / 80 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "69238-1422-8", "marketing_start_date": "20181023"}], "brand_name": "Naproxen Sodium and Diphenhydramine HCl", "product_id": "69238-1422_b9db3e35-7654-4bf3-8536-38f56b8780c7", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "69238-1422", "generic_name": "Naproxen Sodium and Diphenhydramine", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium and Diphenhydramine HCl", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA209726", "marketing_category": "ANDA", "marketing_start_date": "20181023", "listing_expiration_date": "20261231"}